Association between allergies and multiple sclerosis: a systematic review and meta-analysis

Area of Science:

• Immunology
• Neurology
• Epidemiology

Background:

• Multiple sclerosis (MS) is a central nervous system inflammatory disease characterized by a type 1 immune response (Th1).
• Allergic diseases typically involve a type 2 immune response (Th2) with elevated cytokines.
• The potential coexistence of Th1 and Th2 dominant diseases in individuals, including MS and allergies, remains a subject of debate.

Purpose of the Study:

• To systematically review and meta-analyze existing clinical and epidemiological studies.
• To determine if a statistically significant association exists between allergic diseases and multiple sclerosis.
• To clarify the controversial relationship between MS and allergies.

Main Methods:

• A comprehensive literature search was conducted for studies published up to July 2009.
• Ten epidemiological studies assessing the association between allergic diseases and MS were included in the meta-analysis.
• Statistical analysis, including odds ratios (OR) and confidence intervals (CI), was performed.

Main Results:

• No evidence was found to support an association between multiple sclerosis and allergic diseases overall (OR: 0.91; 95% CI: 0.68-1.23).
• Specific allergic conditions, including asthma (OR: 0.83; 95% CI: 0.48-1.44), allergic rhinitis (OR: 0.81; 95% CI: 0.59-1.12), and eczema (OR: 0.93; 95% CI: 0.71-1.23), showed no significant association with MS.
• The meta-analysis indicated a lack of a statistically significant link between these conditions.

Conclusions:

• The current body of evidence does not support a link between allergic diseases and multiple sclerosis.
• The findings suggest that allergies are not a significant risk factor for developing MS.
• Further prospective research is recommended to fully understand any potential complex interactions.